| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 09/28/2000 | CA2365255A1 Human tumor necrosis factor receptor tr9 |
| 09/28/2000 | CA2365247A1 49 human secreted proteins |
| 09/28/2000 | CA2365223A1 46 human secreted proteins |
| 09/28/2000 | CA2365104A1 Anti-p53 antibodies |
| 09/28/2000 | CA2361221A1 Novel protein which induces chondrocyte differentiation |
| 09/27/2000 | EP1038970A2 Method for producing L-glutamic acid |
| 09/27/2000 | EP1038969A2 Process for the fermentative preparation of L-amino acids using coryneform bacteria |
| 09/27/2000 | EP1038968A2 Method for producing shikimic acid |
| 09/27/2000 | EP1038966A1 Temperature sensitive plasmid for coryneform bacteria |
| 09/27/2000 | EP1038963A2 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 09/27/2000 | EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae |
| 09/27/2000 | EP1038959A1 Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
| 09/27/2000 | EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines |
| 09/27/2000 | EP1038951A1 Synthetic medium for cultivating lactobacillus and/or bifidobacteria |
| 09/27/2000 | EP1038035A1 METHOD FOR IDENTIFYING $i(ESCHERICHIA COLI) STRAIN DSM 6601 |
| 09/27/2000 | EP1038011A2 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 09/27/2000 | EP1038010A2 Gram-positive microorganism formate transporters |
| 09/27/2000 | EP1038007A2 Mutant bacillus licheniformis alpha-amylase |
| 09/27/2000 | EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection |
| 09/27/2000 | EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 09/27/2000 | EP1037998A1 guaA POLYPEPTIDES |
| 09/27/2000 | EP1037985A1 Restin and methods of use thereof |
| 09/27/2000 | EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 09/27/2000 | EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 09/27/2000 | EP1037980A1 G-protein coupled receptors associated with immune response |
| 09/27/2000 | EP1037976A1 Single-chain polypeptides comprising troponin i and troponin c |
| 09/27/2000 | EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/27/2000 | EP1037900A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 09/27/2000 | EP1037664A1 Vaccines containing attenuated bacteria |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 09/27/2000 | EP0677116B1 A process for producing immunosuppressives and a novel microbial species to be employed therein |
| 09/27/2000 | EP0651785B1 ALKALOPHILIC -i(BACILLUS sp. AC13) AND PROTEASE, XYLANASE, CELLULASE OBTAINABLE THEREFROM |
| 09/27/2000 | CN1268180A Broad-spectrum delta-endotoxins |
| 09/27/2000 | CN1268179A Microbial swollenin protein, DNA sequences encoding such swollenins and method of producing such swoolenins |
| 09/27/2000 | CN1268172A Novel lactic acid bacteria |
| 09/27/2000 | CN1268029A High-activity phytase granulate |
| 09/27/2000 | CN1267734A Process for producing L-amino acid with rod-shaped bacteria through fermentation |
| 09/27/2000 | CN1056883C Process for producing avermectins B and cultures therefor |
| 09/27/2000 | CN1056880C Synthetic insecticidal crystal protein gene |
| 09/27/2000 | CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 09/27/2000 | CN1056876C Cultivation method for preparing oral live typhoidvaccine |
| 09/27/2000 | CN1056849C Fungistatin derivate and its preparing method and its application in pharmacy |
| 09/26/2000 | US6124447 Nucleic acid sequence coding protein which serves as a substrate for cathepsins and has a enzymatic activity which releases phosphoric acid from preferential proteins; for use as an insecticide |
| 09/26/2000 | US6124430 Amino acid squences useful as a reagent in an immunoassay for measuring and detection of heart hormone protein |
| 09/26/2000 | US6124429 Fibrous protein to be used as biocompatible polymer for surgical sutures, artificial blood vessels and artificial tissues |
| 09/26/2000 | US6124130 Microorganism cultures for removing sulfur from petroleum distillates |
| 09/26/2000 | US6124126 Complementary DNA for rice chitinase having lytic activity against moulds and bacteria, and vector containing said complementary DNA and transformant |
| 09/26/2000 | US6124121 Culturing escherichia bacterium in a culture medium to produce and accumulate l-leucine in the medium, and recovering l-leucine from the medium |
| 09/26/2000 | US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides |
| 09/26/2000 | US6124117 Polysaccharide binding fusion proteins and conjugates |
| 09/26/2000 | US6124113 Fermentative carotenoid production |
| 09/26/2000 | US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control |
| 09/26/2000 | US6124098 Rapid detection of antibiotic resistance in mycobacterium tuberculosis |
| 09/26/2000 | US6124097 Transformed microorganism cells containing nucleotide sequence coding polypeptides of interest |
| 09/26/2000 | US6124094 Zoogloeal and hyphomicrobium spp. nucleic acids |
| 09/26/2000 | US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic |
| 09/26/2000 | US6123938 Human urinary hyaluronidase |
| 09/26/2000 | CA2268710C Improved enzymatic oxidation of ceph c to glutaryl-7-amino cephalosporanic acid |
| 09/26/2000 | CA2044550C Method for the biological preparation of hydroxyvitamin d compounds |
| 09/26/2000 | CA1341101C Recombinant c-terminal .alpha.- amidating enzyme |
| 09/21/2000 | WO2000055357A1 Device and method for microbial susceptibility testing |
| 09/21/2000 | WO2000055343A2 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 09/21/2000 | WO2000055342A1 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 09/21/2000 | WO2000055341A1 Anti-viral vectors |
| 09/21/2000 | WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/21/2000 | WO2000055200A1 50 human secreted proteins |
| 09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
| 09/21/2000 | WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins |
| 09/21/2000 | WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 09/21/2000 | WO2000054789A1 Bacterial membrane fractions with adjuvant effect |
| 09/21/2000 | WO2000040603A3 Production of recombinant monellin using methylotrophic yeast expression system |
| 09/21/2000 | WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY |
| 09/21/2000 | WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/21/2000 | WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/21/2000 | DE19912384A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the fermentative preparation of L-amino acids using coryneform bacteria |
| 09/21/2000 | CA2367917A1 Bacterial membrane fractions with adjuvant effect |
| 09/21/2000 | CA2367211A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 09/21/2000 | CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction |
| 09/21/2000 | CA2365232A1 Device and method for microbial susceptibility testing |
| 09/21/2000 | CA2364667A1 Recombinant haemophilus influenzae adhesin proteins |
| 09/21/2000 | CA2364637A1 50 human secreted proteins |
| 09/20/2000 | EP1036847A1 Oligonucleotide primers for efficient reverse transcription of Hepatitis C Virus (HCV) RNA and methods of use thereof |
| 09/20/2000 | EP1036845A2 Downstream genes of tumor suppressor WT1 |
| 09/20/2000 | EP1036841A1 Sugar super-tolerant yeast for confectionery and bakery |
| 09/20/2000 | EP1036190A1 A method for producing hydroxycarboxylic acids by auto-degradation of polyhydroxyalkanoates |
| 09/20/2000 | EP1036186A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
| 09/20/2000 | EP1036168A1 Purification and microsequencing of hyaluronidase isozymes |
| 09/20/2000 | EP1036167A2 Nuclear targeting by means of streptococcal protein h |
| 09/20/2000 | EP1036160A1 Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain |
| 09/20/2000 | EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/20/2000 | EP0775211B1 Fumonisin detoxification enzymes |
| 09/20/2000 | EP0766735B1 Class bi and ci scavenger receptors |
| 09/20/2000 | EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis |
| 09/20/2000 | EP0672057B1 Analogs of pth |
| 09/20/2000 | EP0600865B1 Xylanase production |
| 09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/20/2000 | EP0495836B2 Dye transfer inhibition |